Ambrx Biopharma soars on $2 billion takeover by Johnson & Johnson
Ambrx Biopharma (AMAM) - Get Free Report shares soared in early Monday trading after the cancer-drug specialists agreed to a $2 billion takeover by pharma giant Johnson & Johnson (…
Ambrx Biopharma (AMAM) - Get Free Report shares soared in early Monday trading after the cancer-drug specialists agreed to a $2 billion takeover by pharma giant Johnson & Johnson (…
